These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8475858)

  • 21. ["We have a high research potential." Prof. Dr. med. H. D. Schlumberger, Bayer, and Dr. E. Schrinner, Hoechst, interpret the cooperation of both companies in AIDS research. Interview by T. U. Keil].
    Schlumberger HD; Schrinner E
    Fortschr Med; 1988 Oct; 106(29):22-3. PubMed ID: 3234996
    [No Abstract]   [Full Text] [Related]  

  • 22. Are orphan product program funds underused by nuclear medicine researchers?
    Harby K
    J Nucl Med; 1988 Jun; 29(6):1011-2. PubMed ID: 3373310
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA clearance for ritonavir in children with AIDS.
    AIDS Patient Care STDS; 1997 Jun; 11(3):194. PubMed ID: 11361797
    [No Abstract]   [Full Text] [Related]  

  • 24. Gore under fire in controversy over South Africa AIDS drug law.
    Wadman M
    Nature; 1999 Jun; 399(6738):717-8. PubMed ID: 10391225
    [No Abstract]   [Full Text] [Related]  

  • 25. Indian company seeks US approval for generic AIDS drugs.
    Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779
    [No Abstract]   [Full Text] [Related]  

  • 26. Forum to advance trials for AIDS therapies.
    Macilwain C
    Nature; 1996 Aug; 382(6592):566. PubMed ID: 8757114
    [No Abstract]   [Full Text] [Related]  

  • 27. New medicines in development for AIDS: 1994 survey from the Pharmaceutical Research and Manufacturers of America.
    Pediatr AIDS HIV Infect; 1995 Apr; 6(2):101-10. PubMed ID: 11361382
    [No Abstract]   [Full Text] [Related]  

  • 28. Women and AIDS.
    Franks B
    N J Med; 2004 Nov; 101(11):76, 75. PubMed ID: 15605802
    [No Abstract]   [Full Text] [Related]  

  • 29. Baxter to open center for AIDS cell therapy.
    Wagner M
    Mod Healthc; 1992 Jan; 22(4):16. PubMed ID: 10115913
    [No Abstract]   [Full Text] [Related]  

  • 30. AIDS: advocacy and activism.
    Fedor MA
    Nurs Health Care; 1991 Apr; 12(4):177. PubMed ID: 2020401
    [No Abstract]   [Full Text] [Related]  

  • 31. Rights, patents, markets and the global AIDS pandemic.
    Gathii JT
    Fla J Int Law; 2002; 14(2):261-352. PubMed ID: 16526139
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug companies seek trial participants.
    AIDS Alert; 1995 Jun; 10(6):82. PubMed ID: 11362432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AIDS treatment drugs: clinical trials and compassionate use.
    Levine RJ
    AIDS Public Policy J; 1987; 2(2):6-8. PubMed ID: 11650031
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmaceutical companies testing 91 AIDS drugs.
    MCN Am J Matern Child Nurs; 1993; 18(2):113. PubMed ID: 8492646
    [No Abstract]   [Full Text] [Related]  

  • 35. The scientific agenda for AIDS.
    Fauci AS
    Issues Sci Technol; 1988; 4(2):33-42. PubMed ID: 10287932
    [No Abstract]   [Full Text] [Related]  

  • 36. AIDS and drug pricing: in search of a policy.
    Salbu SR
    Wash Univ Law Q; 1993; 71(3):691-734. PubMed ID: 11652750
    [No Abstract]   [Full Text] [Related]  

  • 37. No money, no meds.
    Mabry M
    Newsweek; 1999 Jul; 134(2):32-3. PubMed ID: 10538648
    [No Abstract]   [Full Text] [Related]  

  • 38. Understanding the costs of pharmaceuticals.
    Valenti WM
    AIDS Read; 2004 Sep; 14(9):467-8, 471. PubMed ID: 15457597
    [No Abstract]   [Full Text] [Related]  

  • 39. Recent changes in the use of experimental drugs.
    Gould SJ
    J Health Care Mark; 1989 Jun; 9(2):52-4. PubMed ID: 10293676
    [No Abstract]   [Full Text] [Related]  

  • 40. Future of ICC debated. Inter-Company Collaboration for AIDS Drug Development.
    Smart T
    GMHC Treat Issues; 1995 Jun; 9(6):9. PubMed ID: 11362692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.